Litcius/Paper detail

Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine

Alexis Mathian, Matthieu Mahévas, Julien Rohmer, Mathilde Roumier, Fleur Cohen‐Aubart, Blanca Amador-Borrero, Audrey Barrelet, Cécile Chauvet, Thibaud Chazal, Michel Delahousse, Mathilde Devaux, Romain Euvrard, Jehane Fadlallah, Nans Florens, Julien Haroche, Miguel Hié, Laurent Juillard, Raphaël Lhote, Thibault Maillet, G. Richard-Colmant, Jean Baptiste Palluy, M. Pha, Laurent Pérard, Philippe Rémy, Étienne Rivière, D. Sène, P. Sève, Capucine Morélot-Panzini, Jean‐François Viallard, Jean-Simon Virot, Neïla Benameur, Noël Zahr, Hans Yssel, Bertrand Godeau, Zahir Amoura

2020Annals of the Rheumatic Diseases253 citationsDOIOpen Access PDF

Topics & Concepts

MedicineHydroxychloroquineRheumatologyContext (archaeology)Internal medicineOutbreakImmunologyDiseaseInfectious disease (medical specialty)Coronavirus disease 2019 (COVID-19)VirologyBiologyPaleontologySystemic Lupus Erythematosus ResearchCOVID-19 Clinical Research StudiesInflammasome and immune disorders
Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine | Litcius